These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 991109)

  • 1. Nonspecific lymphocyte cytotoxicity in patients with malignant melanoma, renal cell carcinoma, and sarcomas, and in nontumor patients.
    Bukowski RM; Barna B; Deodhar SD; Hewlett JS
    Cancer; 1976 Nov; 38(5):1962-7. PubMed ID: 991109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase of lymphocyte-mediated tumor-cell destruction by certain patient sera.
    Hellström I; Hellström KE; Warner GA
    Int J Cancer; 1973 Sep; 12(2):348-53. PubMed ID: 4792348
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor-specific cellular cytotoxicity to human sarcomas: evidence for a cell-mediated host immune response to a common sarcoma cell-surface antigen.
    Cohen AM; Ketcham AS; Morton DL
    J Natl Cancer Inst; 1973 Mar; 50(3):585-9. PubMed ID: 4513520
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro cell-mediated immune reactions of melanoma and colorectal carcinoma patients demonstrated by long-term 51chromium assays.
    Steele G; Sjögren HO; Stadenberg I
    Int J Cancer; 1976 Jan; 17(1):27-39. PubMed ID: 1248900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A long-term 51chromium assay for in vitro cell-mediated tumor immunity. Correlation with simultaneously performed microplate assays.
    Steele G; Sjögren HO; Lannerstad O; Stadenberg I
    Int J Cancer; 1975 Oct; 16(4):682-93. PubMed ID: 1176212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCG-induced protection against malignant melanoma: possible immunospecific effect in a murine system.
    Faraci RP; Barone J; Schour L
    Cancer; 1975 Feb; 35(2):372-7. PubMed ID: 1111914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant melanoma: specific immunity induced by bacillus Calmette-Guérin in BALB-c mice.
    Faraci RP; Schour L
    Science; 1974 Jul; 185(4145):68-9. PubMed ID: 4599426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune cytolysis of murine tumor cells mediated by xenogeneic "immune" RNA.
    Kern DH; Pilch YH
    Int J Cancer; 1974 May; 13(5):679-88. PubMed ID: 4843880
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphocyte reactivity in cancer patients: correlation with tumor histology and clinical stage.
    Catalona WJ; Sample WF; Chretien PB
    Cancer; 1973 Jan; 31(1):65-71. PubMed ID: 4683045
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro assessment of cell-mediated immunity in patients with renal cell carcinoma.
    Montie JE; Straffon RA; Deodhar SD; Barna B
    J Urol; 1976 Mar; 115(3):239-42. PubMed ID: 1255882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte toxicity test in clinical melanoma.
    Veronesi U; Cascinelli N; Fossati G; Canevari S; Balzarini G
    Eur J Cancer (1965); 1973; 9(11-12):843-6. PubMed ID: 4804311
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma.
    Currie GA; Lejeune F; Fairley GH
    Br Med J; 1971 May; 2(5757):305-10. PubMed ID: 4930209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic lymphocytes. II. Antagonism and synergism between serum factors and lymphocytes of patients with sarcomas as tested against cultured tumor cells.
    Sinkovics JG; Ahmed N; Hrgovcic MJ; Cabiness JR; Wilbur JR
    Tex Rep Biol Med; 1972; 30(4):347-60. PubMed ID: 4121149
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular immunity to a common human sarcoma antigen and its specific inhibition by sera from patients with growing sarcomas.
    Cohen AM; Ketcham AS; Morton DL
    Surgery; 1972 Oct; 72(4):560-7. PubMed ID: 4506654
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique.
    Jagarlamoody SM; Aust JC; Tew RH; McKhann CF
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1346-50. PubMed ID: 4331089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular immunity against tumor-associated antigens in humans: lymphocyte stimulation and skin reaction.
    Vánky R; Klein E; Stjernswärd J; Nilsonne U
    Int J Cancer; 1974 Aug; 14(2):277-88. PubMed ID: 4376515
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody-dependent cell-mediated cytotoxicity for human monolayer target cells bearing blood group and transplantation antigens and for melanoma cells.
    Kodera Y; Bean MA
    Int J Cancer; 1975 Oct; 16(4):579-92. PubMed ID: 1080751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen.
    Lamon EW; Skurzak HM; Klein E; Wigzell H
    J Exp Med; 1972 Nov; 136(5):1072-9. PubMed ID: 4117188
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytotoxicity mediated by human lymphocyte-dependent antibody in a rapid assay with adherent target cells.
    Yust I; Wunderlich JR; Mann DL; Buell DN
    J Immunol; 1973 Jun; 110(6):1672-81. PubMed ID: 4712926
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune factors in human cancer: malignant melanomas, skeletal and soft tissue sarcomas.
    Morton DL; Eilber FR; Malmgren RA
    Prog Exp Tumor Res; 1971; 14():25-42. PubMed ID: 5002728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.